The Centers for Disease Control and Prevention is investigating whether or not the United States ruling class’ “vaccine” stockpile for the bird flu is “well matched” to the virus. Based on new information and more human cases, the CDC allegedly will probe how these mutations in the virus will impact the stockpile of injections.
The CDC will center its investigation on whether the U.S. stockpile of bird flu vaccines is still well matched to the virus after discovering recent mutations and human infections. Though no human-to-human transmission has been identified, the government has built a repository of 4.8 million vaccine doses in case the risk the virus poses increases. It aims to have 10 million within the first quarter of 2025. It’s also supporting Moderna Inc. in its effort to develop an mRNA bird flu vaccine.
According to Medical Xpress, the CDC said Friday it identified genetic changes present in the virus, known commonly as H5N1, after sequencing samples from three people with the infection in California. The nation’s top dairy state has identified six human cases this month, bringing the total number of U.S. infections this year to 20. Almost all have been workers in contact with sick animals.
The U.S. has also been ramping up its supply of bird flu vaccines as a nationwide outbreak among poultry and dairy cows spreads. About 300 dairy herds across 14 states have been impacted. The problem, as we’ve stated before, is how do they know what “mutations” will occur and how will they adequately prepare a “vaccine” that’s safe and effective for those mutations.
Personally, we’d expect the bird flu “vaccines” to work almost as well as the COVID-19 mRNA injections.
The CDC’s latest sequencing effort found no changes that increased the infectivity or transmissibility among humans. The agency believes that the immediate risk
The remainder of this article is available in its entirety at SHTF Plan